CTN Newsletter: Pathways

Jun 1, 2019 — Pathways June 2019 (Volume 9, Issue 2)

FES PET: Headed Toward the Clinic?
Jan 1, 2019 — Pathways January 2019 (Volume 9, Issue 1)

18F Flurpiridaz Shows Promise as a Diagnostic Imaging Agent for CAD
Jun 1, 2018 — Pathways June 2018 (Volume 8, Issue 2)

Clinical Trials Network Launching PET Phantom Program for Compliance with New Joint Commission Requirements
Jan 1, 2018 — Pathways January 2018 (Volume 8, Issue 1)

The Promise of Lu-177-based Radiotherapies
Jun 1, 2017 — Pathways June 2017 (Volume 7, Issue 2)

68Ga-PSMA-11 PET/CT Clinical Trial Underway
Jan 1, 2017 — Pathways January 2017 (Volume 7, Issue 1)

Two New PET Imaging Agents Approved
Jun 1, 2016 — Pathways June 2016 (Volume 6, Issue 2)

PET Imaging of Immunotherapy
Jan 1, 2016 — Pathways January 2016 (Volume 6, Issue 1)

CTN Provides Academic CRO Services
Jun 1, 2015 — Pathways June 2015 (Volume 5, Issue 2)

The CTN Oncology Phantom Program: Evaluating 6 Years of Scanner Performance Data
Jan 1, 2015 — Pathways January 2015 (Volume 5, Issue 1)

PET in Prostate Cancer: A Focus on C-11 Choline
Jun 1, 2014 — Pathways June 2014 (Volume 4, Issue 2)

The Dawn of in vivo Tau Imaging
Jan 1, 2014 — Pathways January 2014 (Volume 4, Issue 1)

68Ga PET/CT Advances in the United States: A Personal Journey
Jun 1, 2013 — Pathways June 2013

The DOTA Discussion: TOC, TATE and NOC
Jan 1, 2013 — Pathways January 2013

Do You Need an IND?
May 1, 2011 — Pathways May 2011

FDA New Rule for cGMP: Updates for Radiopharmaceutical Manufacturers
Sep 1, 2010 — Pathways September 2010

The Radiotracer Approval Bottleneck: Improving the Flow through the Pipeline
May 1, 2010 — Pathways May 2010

Siemens Demonstration Project on Scanner Validation for FLT Multicenter Study
Jan 1, 2010 — Pathways January 2010

State of the Network